Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
64Cu SPION
- Development stage
- Unknown
- Lead developer
- RMIT University
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
64Cu SPION is a dual PET-CT and PET-MRI cell tracking technology used primarily for imaging and tracking purposes, particularly in cancer therapies like CAR-T cell therapy. It combines the imaging capabilities of superparamagnetic iron oxide nanoparticles (SPIONs) with the radioactive tracer Copper-64 (\(^{64}\)Cu) for enhanced visualization in both PET and MRI modalities.
- Other names
- Copper-64 superparamagnetic iron oxide nanoparticlesCopper64 superparamagnetic iron oxide nanoparticlesCopper 64 superparamagnetic iron oxide nanoparticles
Beyond the preview
Go deeper on 64Cu SPION.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 64Cu SPION.